The biosecurity awareness-implementation gap among organizations ordering synthetic DNA in Japan

Introduction The widespread adoption of AI and synthetic biology is creating value while also bringing bio-risk management challenges into sharper focus. Risk mitigation is commonly divided into biosafety, which aims to prevent exposure to or release of biological agents, and biosecurity, which aims to deter theft, diversion, and misuse. In recent years, the scope of biosecurity has expanded to include pandemic prevention and the governance of dual-use technologies. DNA synthesis, which converts digital sequence information into physical molecules, serves as a critical gateway for managing misuse potential. Consequently, sequence screening upon order acceptance and customer screening have become key focal points for risk management. Methods To assess the current status of biosecurity awareness and implementation among organizations involved in ordering synthetic DNA in Japan, we conducted an anonymous web-based survey of member organizations of the Japan Bioindustry Association across four domains (regulatory and institutional frameworks, risk awareness, social responsibility, and sequence screening) and analyzed responses from 107 organizations. Results While overall awareness was high, the development of internal misuse-prevention policies and the establishment of criteria and standard operating procedures (SOPs) for sequence-screening determinations lagged behind. In particular, sequence screening showed a pronounced gap between recognition of its importance and procedural preparedness. Discussion These findings underscore the importance of developing and disseminating practical, up-to-date, and implementable guidance to support the transition from awareness to operational readiness.

Authors

Publication Details

Journal
Frontiers in Bioengineering and Biotechnology
Published
2026-11-16
DOI
https://doi.org/10.3389/fbioe.2026.1840891
Primary Topic
Global Security and Public Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The biosecurity awareness-implementation gap among organizations ordering synthetic DNA in Japan

Kentaro Hayashi
2 links
Frontiers in Bioengineering and Biotechnology
Global Security and Public Health
article

The biosecurity awareness-implementation gap among organizations ordering synthetic DNA in Japan

Kentaro Hayashi
article en

Abstract

Introduction The widespread adoption of AI and synthetic biology is creating value while also bringing bio-risk management challenges into sharper focus. Risk mitigation is commonly divided into biosafety, which aims to prevent exposure to or release of biological agents, and biosecurity, which aims to deter theft, diversion, and misuse. In recent years, the scope of biosecurity has expanded to include pandemic prevention and the governance of dual-use technologies. DNA synthesis, which converts digital sequence information into physical molecules, serves as a critical gateway for managing misuse potential. Consequently, sequence screening upon order acceptance and customer screening have become key focal points for risk management. Methods To assess the current status of biosecurity awareness and implementation among organizations involved in ordering synthetic DNA in Japan, we conducted an anonymous web-based survey of member organizations of the Japan Bioindustry Association across four domains (regulatory and institutional frameworks, risk awareness, social responsibility, and sequence screening) and analyzed responses from 107 organizations. Results While overall awareness was high, the development of internal misuse-prevention policies and the establishment of criteria and standard operating procedures (SOPs) for sequence-screening determinations lagged behind. In particular, sequence screening showed a pronounced gap between recognition of its importance and procedural preparedness. Discussion These findings underscore the importance of developing and disseminating practical, up-to-date, and implementable guidance to support the transition from awareness to operational readiness.

Frontiers in Bioengineering and BiotechnologyVol. 14
Global Security and Public Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon